Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.44
-0.03 (-0.26%)
Apr 29, 2025, 10:18 AM EDT - Market open

Nurix Therapeutics Balance Sheet

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Feb '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2018 - 2019
Cash & Equivalents
75.9211054.6364.4780.51119.36
Upgrade
Short-Term Investments
473.76499.59233.28244.67215.21161.79
Upgrade
Cash & Short-Term Investments
549.68609.58287.91309.14295.72281.15
Upgrade
Cash Growth
125.28%111.73%-6.87%4.54%5.18%645.36%
Upgrade
Accounts Receivable
----67.5
Upgrade
Other Receivables
2.11.50.81.11.14.25
Upgrade
Receivables
2.11.50.81.17.111.75
Upgrade
Prepaid Expenses
11.928.36.88.218.295.54
Upgrade
Total Current Assets
563.7619.39295.5318.45311.12298.43
Upgrade
Property, Plant & Equipment
44.8145.947.9529.5125.356.67
Upgrade
Long-Term Investments
--7.4263.88137.1990.89
Upgrade
Long-Term Deferred Charges
-0.10.50.50.5-
Upgrade
Other Long-Term Assets
6.533.964.224.422.620.35
Upgrade
Total Assets
615.04669.34355.6416.76476.77396.34
Upgrade
Accounts Payable
8.411.486.45.066.653.41
Upgrade
Accrued Expenses
40.3434.4824.1920.8413.827.55
Upgrade
Current Portion of Leases
6.648.017.495.533.85-
Upgrade
Current Income Taxes Payable
1.331.240.030.090.080.07
Upgrade
Current Unearned Revenue
30.5938.3648.137.6341.2132.8
Upgrade
Other Current Liabilities
2.692.280.751.50.660.7
Upgrade
Total Current Liabilities
89.9995.8586.9670.6666.2644.54
Upgrade
Long-Term Leases
19.9820.2923.136.439.19-
Upgrade
Long-Term Unearned Revenue
24.1526.2145.0235.9759.0260.69
Upgrade
Other Long-Term Liabilities
-----0.85
Upgrade
Total Liabilities
134.13142.35155.11113.06134.47106.07
Upgrade
Common Stock
0.080.080.050.050.050.04
Upgrade
Additional Paid-In Capital
1,2761,266746.3709.22563.76393.84
Upgrade
Retained Earnings
-795.12-738.77-545.2-401.25-220.89-103.7
Upgrade
Comprehensive Income & Other
0.230.15-0.66-4.32-0.610.09
Upgrade
Total Common Equity
480.92526.99200.49303.7342.3290.27
Upgrade
Shareholders' Equity
480.92526.99200.49303.7342.3290.27
Upgrade
Total Liabilities & Equity
615.04669.34355.6416.76476.77396.34
Upgrade
Total Debt
26.6228.330.6111.9613.04-
Upgrade
Net Cash (Debt)
523.06581.28264.72361.06419.87281.15
Upgrade
Net Cash Growth
132.34%119.59%-26.68%-14.01%49.34%645.36%
Upgrade
Net Cash Per Share
7.048.664.877.439.7917.94
Upgrade
Filing Date Shares Outstanding
76.2475.8948.8947.2744.7438.91
Upgrade
Total Common Shares Outstanding
76.2375.8748.7247.1744.6638.86
Upgrade
Working Capital
473.72523.53208.55247.79244.86253.9
Upgrade
Book Value Per Share
6.316.954.126.447.667.47
Upgrade
Tangible Book Value
480.92526.99200.49303.7342.3290.27
Upgrade
Tangible Book Value Per Share
6.316.954.126.447.667.47
Upgrade
Machinery
43.4841.0433.8327.6219.315.37
Upgrade
Leasehold Improvements
5.645.143.243.833.082.66
Upgrade
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q